Search - tctmd.com

Displaying 201 - 215 of 215

Sort: Relevancy | Date

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Daily News

IVUS Guidance of DES Implantation Improves Outcomes

September 28, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Jason Kahn

January 12, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

Jason Kahn

January 02, 2011

Advertisement

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

IVUS Guidance of DES Implantation Improves Outcomes

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

DES Show Advantage over BMS for Heart Transplant Complication

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

EES Show Long-term Safety Advantage over SES

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Studies Support DES Use in Diabetics, But Results Vary by Device

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

TCTMD’s Top 10 Most Popular News Stories for 2010

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content